Loading...

CL: Future Cost Optimization Will Drive Competitive Advantage Amid Category Headwinds

Published
18 Jul 24
Updated
24 Feb 26
Views
446
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
3.8%
7D
-1.4%

Author's Valuation

US$96.681.5% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Last Update 24 Feb 26

Fair value Increased 8.76%

CL: 2030 Plan And Emerging Markets Will Drive Balanced 2026 Setup

Analysts have raised their implied price target for Colgate-Palmolive by about $8 to reflect higher conviction in the company’s 2030 plan, product innovation pipeline and emerging market exposure, as well as refreshed views on sector valuations.

Analyst Commentary

Recent research has centered on how Colgate-Palmolive’s 2030 plan, product pipeline and emerging market footprint feed into both growth potential and current valuation. Price target changes from several large firms, including BofA, Goldman Sachs, Wells Fargo, JPMorgan and others, reflect different views on how effectively the company can execute on these priorities over the next few years.

Bullish Takeaways

  • Bullish analysts highlight the 2030 plan and SGPP initiatives as key drivers for earnings growth, with multiple price target increases into the US$100 to US$105 range tied to higher confidence in execution and business momentum.
  • Exposure to emerging markets is seen as a key support for long term growth. Some analysts point to early signs of improvement and a lower reliance on what they describe as a stretched U.S. market.
  • Several banks link their higher targets to Colgate-Palmolive’s product innovation pipeline, arguing that new launches can support both revenue growth and pricing power over time.
  • Upgrades to ratings, including moves to Overweight and Equal Weight, are framed around a more balanced risk and reward profile and an assessment that recent softness in results is already reflected in the share price.

Bearish Takeaways

  • Bearish analysts point to a potentially challenging setup for large cap consumer staples into 2026, with expectations that volume growth may remain weak and pricing gains muted, which could cap earnings progress.
  • Some research flags continued softness in recent quarters as a risk, with a view that the company still needs to prove that growth can reaccelerate in 2026 to justify higher valuation multiples.
  • Where price targets have been lowered, analysts are cautious that sector wide headwinds and limited volume improvement could limit upside even if Colgate-Palmolive executes on its internal plans.
  • Equal Weight ratings and more tempered target moves suggest that a portion of the market sees current valuation as fair, with less room for error if the 2030 plan or emerging market improvement takes longer to play out than bullish analysts expect.

What's in the News

  • Colgate-Palmolive issued full year 2026 earnings guidance, expecting net sales to be up 2% to 6%, including a low single digit positive impact from foreign exchange, with organic sales growth projected at 1% to 4% and an approximately 20 basis point impact from exiting the private label pet food business (Key Developments).
  • For 2026, the company expects gross profit margin expansion, with advertising planned to be higher both in absolute dollars and as a percentage of net sales, and is guiding to double digit earnings per share growth on a GAAP basis (Key Developments).
  • Between October 1, 2025 and December 31, 2025, Colgate-Palmolive repurchased 0 shares for US$0 under its ongoing buyback, while total purchases under the program announced March 20, 2025 stand at 5,887,029 shares, or 0.73%, for US$515.76m (Key Developments).

Valuation Changes

  • Fair Value: updated from $88.89 to $96.68, reflecting a modest upward revision to the implied valuation level.
  • Discount Rate: adjusted slightly from 6.96% to 6.98%, indicating a very small change in the required return used in the model.
  • Revenue Growth: updated assumption from 3.23% to 3.75%, indicating a slightly higher expected pace for future dollar sales expansion.
  • Net Profit Margin: revised from 15.66% to 15.33%, representing a small reduction in expected profitability on each dollar of revenue.
  • Future P/E: moved from 24.79x to 26.70x, indicating a higher multiple applied to projected earnings in the updated view.
12 viewsusers have viewed this narrative update

Key Takeaways

  • Expansion in oral care and focus on emerging markets, with premiumization and innovation, drive sustained volume growth and strengthen global brand positioning.
  • Investment in AI, digital transformation, and productivity boosts efficiencies, enabling reinvestment into growth and supporting stable margins and resilience against market cycles.
  • Persistent cost pressures, cautious consumer behavior, and competitive challenges in major markets are constraining margin expansion, topline growth, and long-term revenue prospects.

Catalysts

About Colgate-Palmolive
    Manufactures and sells consumer products in the United States and internationally.
What are the underlying business or industry changes driving this perspective?
  • Expansion and premiumization of core oral care lines like Colgate Total, coupled with the roll-out of complementary products across 75 markets, are set to capture increased value from emerging middle-class consumers and rising health/hygiene awareness globally-supporting top-line organic sales acceleration and improved pricing power.
  • Emerging markets such as India, Latin America, and Southeast Asia-where rising incomes and urbanization are growing the addressable customer base-remain a strategic focus with stepped-up innovation, brand investment, and price tiering, sustaining long-term volume and revenue growth.
  • Continued investments in AI, digital transformation, and omnichannel demand generation are expected to enhance operational efficiency, customer reach, and data-driven marketing, translating into greater sales effectiveness and margin resilience.
  • Productivity and restructuring initiatives ($200–$300 million over three years) are designed to free up resources for innovation, digital, and R&D investments, enabling incremental margin expansion and additional reinvestment for growth.
  • Category stabilization and long-term brand strength, particularly in daily-use, trusted segments (oral care, pet nutrition), position Colgate-Palmolive to outperform peers as consumer confidence rebounds, supporting consistent earnings growth and de-risking revenue from cyclical downturns.

Colgate-Palmolive Earnings and Revenue Growth

Colgate-Palmolive Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?
  • Analysts are assuming Colgate-Palmolive's revenue will grow by 3.8% annually over the next 3 years.
  • Analysts assume that profit margins will increase from 14.5% today to 15.5% in 3 years time.
  • Analysts expect earnings to reach $3.5 billion (and earnings per share of $4.43) by about September 2028, up from $2.9 billion today.
  • In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 26.1x on those 2028 earnings, up from 23.4x today. This future PE is greater than the current PE for the US Household Products industry at 21.6x.
  • Analysts expect the number of shares outstanding to decline by 1.08% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 6.78%, as per the Simply Wall St company report.

Colgate-Palmolive Future Earnings Per Share Growth

Colgate-Palmolive Future Earnings Per Share Growth

Risks

What could happen that would invalidate this narrative?
  • Consumer caution and category softness in key markets like North America, Brazil, and India could persist due to elevated food inflation and macroeconomic uncertainty, potentially constraining volume growth and revenue.
  • Rising raw material and packaging costs, particularly for palm oil and fats, are significantly impacting gross margin, and relief is uncertain, posing ongoing pressure on net margins and profitability.
  • Increased focus on price pack architecture and value offerings in response to cautious consumers and lower category inflation may limit the company's ability to drive premium pricing, potentially compressing margins and slowing topline growth.
  • Company performance in China and India is being challenged by local market dynamics, with China's Hawley & Hazel business requiring significant repositioning in a highly competitive e-commerce environment and India experiencing urban market sluggishness, both of which could hinder long-term revenue growth in these important markets.
  • Continued exposure to private label competition, especially in the pet food category and key emerging markets, along with the exit from private label production, could negatively impact reported sales growth and overall earnings during the transition period.

Valuation

How have all the factors above been brought together to estimate a fair value?
  • The analysts have a consensus price target of $95.222 for Colgate-Palmolive based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $106.0, and the most bearish reporting a price target of just $83.0.
  • In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be $22.4 billion, earnings will come to $3.5 billion, and it would be trading on a PE ratio of 26.1x, assuming you use a discount rate of 6.8%.
  • Given the current share price of $84.28, the analyst price target of $95.22 is 11.5% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Colgate-Palmolive?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives